Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesInsulin Glargine Safety in Pregnancy: a Transplacental Transfer Study
Diabetes Care, 10/13/09
Pollex EK et al. – Insulin glargine is an extended–action insulin analogue with greater stability and duration of action compared to regular human insulin. The long duration of action and decreased incidence of hypoglycemia provide potential advantages for its use in pregnancy. Insulin glargine, when used at therapeutic concentrations, is not likely to cross the placenta.
Related Articles
Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine
Diabetes Technology & Therapeutics, 10/05/09
Relevance Score: 71%
Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial
Clinical Therapeutics, 11/19/09
Relevance Score: 69%
Rationale, Design, and Baseline Data of the Insulin Glargine (Lantus) Versus Insulin Detemir (Levemir) Treat-To-Target (L2T3) Study: A Multinational, Randomized Noninferiority Trial of Basal Insulin Initiation in Type 2 Diabetes
Diabetes Technology & Therapeutics, 11/17/09
Relevance Score: 68%
No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 10/29/09
Relevance Score: 67%
Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT
Current Medical Research and Opinion, 10/22/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Emerging role of pemetrexed in ovarian cancer
Expert Review of Anticancer Therapy, 12/04/09
Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/03/09
Endometrial Cancer in Postmenopausal Women Using Estradiol-Progestin Therapy
Obstetrics and Gynecology, 12/01/09
Sponsor
Article Search
Sponsor